Related by context. All words. (Click for frequent words.) 85 Gets Approval 83 Enters Agreement 82 Signs Agreement 81 Submits Application 81 Enters Into Agreement 80 Seeks Approval 80 Announce Agreement 80 Obtains Approval 79 Announces Commencement 79 Announces Receipt 79 Announces Completion 79 Awarded Contract 79 Completes Acquisition 79 Receives Order 79 Wins Contract 79 Obtains 79 Signs Definitive Agreement 78 Reports Positive 78 Successfully Completes 78 Announces Termination 78 Signs MOU 78 Announces Proposed 78 Signs Contract 78 Signs Agreements 78 Announce Completion 78 Announces Successful Completion 78 Reaches Agreement 78 Finalizes 78 Completes Purchase 78 Submits 77 Completes Sale 77 Wins Approval 77 Receives Notice 77 Announces Intention 77 Announces Acquisition 77 Finalizes Agreement 77 Announces Successful 77 Announces Intent 77 Enters Into 77 Updates Status 77 Receives Regulatory 77 Takes Steps 77 Completes Successful 77 Inks Pact 77 Commences 76 Announces Positive 76 Announces Expansion 76 Closes Sale 76 Signs LOI 76 Acquires 76 Completes Initial 76 Signs Letter 76 Closes Acquisition 76 Finalizes Acquisition 75 Ink Deal 75 Announces Launch 75 Announce Receipt 75 Enter Into 75 Completes 75 Signs Deal 75 Provides Update 75 Signs Pact 75 Announces Closing 75 Nears Completion 75 Receives Patent 75 Chooses 75 Announces Filing 75 Inks Deal 75 Changes Name 75 Announces Issuance 75 Reach Agreement 75 Receives Approval From 75 Commences Operations 75 Completes Merger 75 Moves Forward 75 Announces Preliminary 75 Subsidiary Signs 75 Receives 75 Strikes Deal 75 Attains 75 Secures Contract 75 Receives FDA Clearance 75 Renews Contract 75 Receives Conditional 74 Deploys 74 Sign Pact 74 Approves 74 Acquires Assets 74 Receives Orphan Drug Designation 74 Signs Licensing Agreement 74 Executes Agreement 74 Secures Financing 74 Receives Clearance 74 Expands 74 Shareholders Approve 74 Jointly Develop 74 Continues Expansion 74 Acquire Assets 74 Extends Deadline 74 Announces 74 Discontinues 74 Announce Partnership 74 Exercises Option 74 Receives Positive 74 Terminates 74 Expands Into 74 Announces Initiation 74 Inks Agreement 73 Provides Updates 73 Files Registration Statement 73 Announces Formation 73 Signs Memorandum 73 Receives Notification 73 Withdraws 73 Reaches Settlement 73 Expand Relationship 73 Opts 73 Subsidiary Receives 73 Announces Expanded 73 Sign Licensing Agreement 73 Certifies 73 Expand Into 73 Initiates 73 Moves Ahead 73 Announce Joint Venture 73 Launches Website 73 Expands Presence 73 Obtains License 73 Launches 73 Announce Collaboration 73 FDA Approves 73 Renews Agreement 73 Shareholders Approve Merger 73 Forms Joint Venture 73 Receives Contract 73 Signs Lease 73 Announces Availability 73 Jointly Announce 73 Announces Signing 73 Subsidiary Acquires 73 Complete Merger 72 Completes Financing 72 Receives Prestigious 72 Receives Authorization 72 Secures Funding 72 Progresses 72 Reaffirms Commitment 72 Receives Commitment 72 Signs MoU 72 Launches Enhanced 72 Launches Innovative 72 Relocates 72 Expands Distribution 72 Enters Joint Venture 72 Gets Boost 72 Paves Way 72 Successfully Closes 72 Goes Live 72 Receives Certification 72 Consummates 72 Announces Shareholder Approval 72 Closes Financing 72 Announces Definitive Agreement 72 Subsidiary Enters 72 Completes Conversion 72 Extends Contract 72 Extends Reach 72 Sets Up 72 Inks Deal With 72 Restructures 72 Recieves 72 Files Patent Application 72 Formalizes 72 Renegotiates 72 Terminates Agreement 72 Adopts 72 Agreement Reached 72 Renames 72 Successfully Completed 72 Inks Contract 72 Annouces 72 Completes Installation 72 Receives Favorable 72 Gears Up 72 Intends 72 Receives Confirmation 72 Signs Long Term 72 Clears Way 71 Panel Backs 71 Finalises 71 Gets Nod 71 Receives Milestone Payment 71 Updates Shareholders 71 Engages 71 Receives Conditional Approval 71 Establish Joint Venture 71 Acquire Stake 71 Joins Forces 71 Provides Guidance 71 Acquires Controlling Interest 71 Completes Purchase Of 71 Enters Into Definitive Agreement 71 Announces Expiration 71 Issues Statement Regarding 71 Achieves Milestone 71 Expands Coverage 71 Completes Enrollment 71 Temporarily Suspends 71 Closes Acquisition Of 71 Rolls Out 71 Regulators Approve 71 Secures 71 Readies 71 Announces Revised 71 Completes Divestiture 71 Submits Proposal 71 Pursues 71 Expands Reach 71 Appoints 71 Announces FDA Clearance 71 Strengthens Its 71 Awarded Patent 71 Divests 71 Provides Update Regarding 71 FDA Clears 71 Confirms Receipt 71 Signs Exclusive 71 Expands Scope 71 Entry Into 71 Cooperates 71 Approves Merger 71 Completes Transaction 71 Extends Tender Offer 71 Announces Resignation 71 Mobilizes 71 Announces Addition 71 Largest Ever 71 Previously Announced 71 Moves Towards 71 Strengthens Position 70 Abandons 70 Acquire 70 Forges Ahead 70 Acquirer Company 70 Postpones 70 Signs Option Agreement 70 Shares Surge 70 Announce Merger 70 Sign Definitive Agreement 70 Issues Guidance 70 Bolsters 70 Completes Acquisitions 70 Approve Merger 70 Suspends 70 Reports Receipt 70 Repays 70 Closes Previously Announced 70 Ceases 70 Successfully Complete 70 Join Forces 70 Significantly Increases 70 Bags Contract 70 Resubmits 70 Moves Toward 70 Implements 70 Acquires Exclusive 70 Increases Stake 70 Waives 70 Moves Closer 70 Announces License Agreement 70 Halts 70 Terminates Contract 70 Mulls 70 Introduces 70 Signs Joint Venture 70 Commends 70 Breaks Ground 70 Stockholders Approve Merger 70 Signs License Agreement 70 Completes Sale Of 70 Has Received 70 Forms Strategic 70 Announces Private Placement 70 Expand Presence 70 Shows Promise 70 Announce Signing 70 Ramps Up 70 Unveils 70 Sells Stake 70 Reach Settlement 70 Files Petition 70 Reorganizes 70 Announce Definitive Agreement 70 Activates 70 Announce License Agreement 70 Officially Opens 70 Beefs Up 70 More Than Doubles 70 Revokes 70 Announce Merger Agreement 70 Announces Effective Date 70 Wins Prestigious 70 Announces Licensing Agreement 70 Positive Results 70 Further Strengthens 70 Successful Completion 70 Completes Asset 70 Completes Expansion 70 Reconfirms 69 Ratifies 69 Commercialize 69 Selects 69 Extends Offer 69 Enters Negotiations 69 Launches Next Generation 69 Finalizes Purchase 69 Raises Funds 69 Files Suit Against 69 Confirms 69 Okays 69 Wraps Up 69 Announces Pricing 69 Increases Capacity 69 Files Lawsuit Against 69 Procures 69 Announce Successful Completion 69 Makes Bid 69 Joins 69 Buys Stake 69 Revolutionizes 69 Gives Nod 69 Pushes Ahead 69 Shareholders Approve Acquisition 69 Completes Private Placement 69 Sign License Agreement 69 Officially Launches 69 Reaches Milestone 69 Receives Positive Opinion 69 Retains 69 Negotiates 69 Announces Cancellation 69 Expands Capabilities 69 Rebrands 69 Enters Into Letter 69 Aquires 69 Recommends Approval 69 Subsidiary Awarded 69 Amends Agreement 69 Enters Into Strategic 69 Announces Divestiture 69 Significantly Expands 69 Inaugurates 69 Completes Tender Offer 69 Applauds 69 Announces Refinancing 69 Opens Doors 69 Introduces Next Generation 69 Repositions 69 Expansion Plans 69 Statement Regarding 69 Receives Tentative Approval 69 Settles Litigation 69 Awarded Contracts 69 Completes Merger With 69 Announces Presentation 69 Snaps Up 69 Achieves Certification 69 Renews 69 Pave Way 69 Reaches Settlement Agreement 69 Expands Relationship 69 Announces Dividend 69 Realigns 69 Withdraws Application 69 Widens 69 Announces Appointment 69 Modernizes 69 Extends 69 Migrates 69 Reaches Deal 69 Zacks Analyst Blog Highlights 69 Standardizes 69 Discloses 69 Undertakes 69 Announces Stock Repurchase 69 Speeds Up 69 Strengthens Presence 69 Closes Private Placement 69 Dedicates 69 Refuses To 69 Receives Accreditation 69 Opens Door 69 Website Launched 68 Court Upholds 68 Announces Stockholder Approval 68 Remains Committed 68 Delist 68 Upholds 68 Secures Long Term 68 Moves Into 68 Announces Non Brokered 68 Announces Publication 68 Provides Operational Update 68 Announce Collaboration Agreement 68 Expands Capacity 68 Makes Debut 68 Net Loss Narrows 68 Withdraws Offer 68 Clears Path 68 Kicks Off 68 Closes Second Tranche 68 Files Shelf Registration Statement 68 Celebrates Opening 68 Acquires Majority Stake 68 Completes Refinancing 68 Gains Momentum 68 Announces Redemption 68 Receives Funding 68 Q3 Loss Widens 68 Announces Enhancements 68 Seeks 68 Acquire Controlling Interest 68 Pledges Support 68 Receives Approvals 68 Sets Record 68 Defers 68 Ink Pact 68 Mutually Agree 68 Accelerates 68 Relaunches 68 Delist From 68 Rescinds 68 Completes Integration 68 Receives Permit 68 Voluntarily Withdraw 68 Expand Collaboration 68 Expand Capacity 68 Completes Previously Announced 68 Achieves Significant 68 Announces Granting 68 Announces Organizational Changes 68 Nears Deal 68 Announces Resumption 68 News Unternehmensnachrichten 68 Enters Into Agreements 68 Regains Compliance 68 Announces Additions 68 Secures Additional 68 Step Closer 68 Announce Strategic 68 Proposes Changes 68 Enters Into Joint Venture 68 Spins Off 68 Shares Soar 68 Reinforces 68 Announce Expiration 68 Receives Approvable Letter 68 Consolidates 68 Final Approval 68 Shares Climb 68 Nominates 68 Announces Consummation 68 Increases Ownership 68 Increases Size 68 Becomes Latest 68 Reach Deal 68 Debuts 68 Solution Helps 68 Completes Patient Enrollment 68 Board Authorizes 68 Announce Licensing Agreement 68 Designates 68 Subsidiary Completes 68 Withdraws From 68 Considers 68 Clears Hurdle 68 Steps Up 68 Revises 68 Significantly Reduces 68 Gets Ready 68 Cancels 68 Sells Shares 68 Completes Transition 68 Intensifies 68 Extends Relationship 68 Agrees 68 Commences Trading 68 Sets Date 68 Awaits Approval 68 Successfully Tests 68 Stockholders Approve 68 Streamlines 68 Submits Biologics License Application 68 Prepares 68 Closes Merger 68 Confirms Commitment 67 Raises Bid 67 Wholly Owned Subsidiary 67 Inks MOU 67 Files Patent 67 Raise Funds 67 Abandons Plans 67 Reacquires 67 Reopens 67 Signs Distribution 67 Takes Delivery 67 Initiates Phase II 67 Aligns 67 Provides Clarification 67 Buy Stake 67 Congratulates 67 Equity Preview 67 Introduces Enhanced 67 Files IND 67 Settlement Reached 67 Update5 67 Net Loss Widens 67 Announces Favorable 67 Panel Recommends 67 Completes Reverse Merger 67 Boosts 67 Announcement Regarding 67 Expects Higher 67 Reschedules 67 Receives Recognition 67 Enhances 67 Pulls Out 67 Revamps 67 Affirms Commitment 67 Announce Settlement 67 Buys Into 67 Acquires Stake 67 Disappoints 67 Announces Retirement 67 Receives Shareholder Approval 67 Regains Compliance With 67 Hits Snag 67 Executes 67 Updates Guidance 67 Successfully Launches 67 Urges 67 Shuts Down 67 Increases Presence 67 Reaches Deal With 67 Quadruples 67 Delays Decision 67 Extends Expiration Date 67 Announces Postponement 67 Begins Shipping 67 Presents Positive 67 Announces Cash Dividend 67 Collaborates 67 Outlines Plans 67 Delists 67 Announces Sponsorship 67 Enrolls First 67 Signs Multi 67 Announce Availability 67 Subsidiary Wins 67 Q4 Loss Widens 67 Monetizes 67 Announces Departure 67 Expresses Support 67 Suspends Operations 67 Reactivates 67 Initiates Clinical Trial 67 Announce Initiation 67 Announce Commencement 67 Elects 67 Submits NDA 67 Expands Portfolio 67 Welcomes 67 Update6 67 Successfully Concludes 67 Expansion Into 67 Announce 67 Sends Letter 67 Nearing Completion 67 Unveils Next Generation 67 Receives Unsolicited 67 Arranges 67 Embarks 67 Modifies 67 Break Ground 67 Awarded Prestigious 67 Enters Strategic 67 Broadens 67 Announces Underwriters Exercise 67 Finalizes Contract 67 Reduces Debt 67 Fortifies 67 Issues Warning 67 Plummets 67 Amends Terms 67 Announces Participation 67 Redeems 67 Furthers 67 Receives Notice From 67 Announces Delisting 67 Reiterates Support 67 Commence Trading 67 Announces Affiliation 67 Study Confirms 67 Awarded Multi 67 Forges Partnership 67 Satisfies 67 Extends Maturity 67 Invests 67 Loses Bid 67 Underway 67 Stays Neutral 67 Receives Fast Track 67 Shares Plunge 67 Strengthens Balance Sheet 67 Makes Waves 67 Announce Exclusive 67 Q2 Loss Widens 67 Commences Production 67 Completes Drilling 67 Sets Stage 67 Earns 67 Boosts Stake 67 Subsidiary Enters Into 67 Confirms Talks 67 Takes Stake 67 Q3 Loss Narrows 67 Long Awaited 67 Sell Stake 66 Files Preliminary Prospectus 66 Equips 66 Reveals Positive 66 Installs 66 Planned Acquisition 66 Ups Stake 66 Acquires Remaining Interest 66 Court Dismisses 66 Doubles Size 66 Validates 66 www.bharatbook.com 66 Acquires Remaining 66 Initiates Voluntary Recall 66 Curtails 66 Settles Lawsuit 66 Denounces 66 Posts Record 66 Intros 66 Receives Permission 66 Makes Strides 66 Obtains Patent 66 Successfully Completes Tender Offer 66 Seeks Proposals 66 Bodes Well 66 Novartis Novo Nordisk 66 Introduces Innovative 66 Posts Higher 66 Lawsuit Filed Against 66 Sees Increase 66 Deadline Extended 66 Introduces Revolutionary 66 Report Examines 66 Raises Stake 66 Reconsiders 66 Provides Preliminary 66 Receives Favorable Ruling 66 Scraps Plans 66 Acquires Controlling Stake 66 Unveils Latest 66 Begins Drilling 66 Draws Attention 66 Patent Issued 66 Expedites 66 Pushes 66 Enters Into License Agreement 66 Bounces Back 66 Filed Against 66 Demonstrates Commitment 66 Receives NASDAQ 66 Revitalizes 66 Enacts 66 Lawmakers Approve 66 Board Unanimously Rejects 66 Offers Unique 66 Q1 Loss Widens 66 Announces Normal Course 66 Q2 Profit Rises 66 Stockholders Approve Acquisition 66 Announces Early Termination 66 Explore Strategic Alternatives 66 Reiterates Commitment 66 Endorses 66 Backs Away 66 Jumps Higher 66 Deepens 66 Swings To 66 Commences Tender Offer 66 Reaches Pact 66 Successfully Deploys 66 Significant Increase 66 Regains 66 Elevates 66 Resigns 66 Obtains FDA 66 Joins Hands 66 Panel Rejects 66 Enlarges 66 Proposes 66 Considers Selling 66 Announces Upcoming 66 Inks Licensing Deal 66 Finalizes Sale 66 Rejects Bid 66 Reassures 66 Q1 Loss Narrows 66 Publishes 66 Declares Dividend 66 Resolve Dispute 66 Seeks Bids 66 Q2 Loss Narrows 66 Heats Up 66 Notifies 66 Strengthens 66 Enters Into Exclusive 66 Sees Strong 66 Renews Commitment 66 Drops Bid 66 Streamlines Operations 66 Holds Talks 66 Eases 66 Announces Proposed Acquisition 66 Pulls Out Of 66 Signs Definitive 66 Formally Launches 66 Withdraws Bid 66 Strongly Supports 66 Gets Thumbs Up 66 Signs Purchase Agreement 66 Reinstates 66 Provide Comprehensive 66 Concludes Successful 66 Collaborates With 66 Warns Against 66 REPLACING 66 Proudly Announces 66 Commences Cash 66 Enters 66 Expands Availability 66 Enlists 66 Mln Quick Facts 66 Establishes Joint Venture 66 Offers Incentives 66 FDA Accepts 66 Gives Boost 66 Deadline Approaching 66 Inaugurate 66 Announce Expanded 66 Launches Unique 66 Entices 66 Identifies Potential 66 Seeks Clarification 66 Hits Milestone 66 Prompts 66 Reaches Agreements 66 Posts Profit 66 Falters 66 Dissolves 66 Little Changed 66 Disposes 66 Q4 Profit Rises 66 Initiates Coverage 66 Enrolls 65 Update4 65 Carries Out 65 Makes Donation 65 Scoops Up 65 Rethinks 65 Lauds 65 Backs Off 65 Refuses 65 Intervenes 65 Ranked Number 65 Regains Full 65 Files Suit 65 Slightly Higher 65 Reaches Settlement With 65 Commence Drilling 65 Deal Reached 65 Q4 Loss Narrows 65 Enters Final 65 Initiates Phase 65 Re Elects 65 Takes Over 65 Readied 65 Announces Tender Offer 65 Gains Ground 65 Takes Lead 65 Minority Stake 65 Lifts Ban 65 Clarifies Status 65 Directors Authorizes 65 Hold Talks 65 Corporation Announces Pricing 65 Renovates 65 Expands Footprint 65 Newly Acquired 65 Seeks Input 65 Reaches 65 Reduces Risk 65 Update7 65 Feds Approve 65 Firm Sues 65 Q3 Profit Rises 65 Announces Repurchase 65 Date Set 65 Inks LOI 65 Holds Annual 65 Bulks Up 65 Reaffirms 65 Plunges 65 Asks 65 Takes Shape 65 Raise Stake 65 Announces Tentative Approval 65 Puts Off 65 Fully Subscribed 65 Announce Formation 65 Settle Patent Litigation 65 Shares Plummet 65 Regulator Approves 65 Posts Wider Loss 65 Declares Increased 65 Qualifies 65 Gets Underway 65 Regains Control 65 Strengthen Ties 65 Cuts Costs 65 Heightens 65 Majority Stake 65 Suffers Setback 65 Earns Top 65 A.M. Best Affirms Ratings 65 Sets Deadline 65 Posts Loss 65 Subsidiary 65 Rebuffs 65 Introduces Unique 65 Present Preclinical Data 65 HSR Waiting Period 65 Anounces 65 Receives Clearance From 65 Closes Down 65 Voluntarily Withdraws 65 Latest Addition 65 Clears 65 Announces Share Repurchase 65 Pressure Mounts 65 Nixes 65 Sets Sights 65 Raises Concerns 65 Hires 65 Shares Tumble 65 Files Complaint Against 65 Breaks Out 65 Spins Out 65 Restates 65 Submits Bid 65 Update3 65 Decides Against 65 Develop Novel 65 Stock Soars 65 Drilling Underway 65 Taps Into 65 Amends Credit 65 Jointly Explore 65 Recommences 65 Gets Subpoena 65 Distribution Pact 65 Significantly Improves 65 Proves Successful 65 Investigates Possible 65 Issues Statement 65 Revives 65 Being Tested 65 Q1 Profit Rises 65 Licensing Deal 65 Could Become 65 Receives Complete Response 65 Shifts Focus 65 Retracts 65 Finalize Agreement 65 Criticizes 65 Prolongs 65 Seeks Buyer 65 Announces Dates 65 Commences Phase 65 Announces Voluntary Delisting 65 Subsidiary Files 65 Million Contract 65 IIROC Halt 65 Initiates Phase III 65 Denies Request 65 CRWESelect CRWESelect.com Highlights 65 Extends Collaboration 65 Postpones Decision 65 FDA Warns 65 Q3 Profit Declines 65 Finalizes Sale Of 65 Puts Pressure 65 Commemorates 65 Adopts Shareholder Rights 65 Settle Dispute 65 Sees Surge 65 Million Financing 65 Commercializes 65 Acquire Majority 65 Improves Customer 65 Promotes 65 Announce Intention 65 Finalizes Deal 65 Receives Endorsement 65 Sweetens 65 Unifies 65 Enters Into Negotiations 65 Strengthens Commitment 65 Files Annual Report 65 Judge Dismisses 65 Makes Headway 65 Announces Dismissal 65 Catches Fire 65 Extends Presence 65 Exceeds Expectations 65 Gets FDA Clearance 65 Help Improve 65 Receives Marketing Authorization 65 Posts Strong 65 Completes Restructuring 65 Initiates Enrollment 65 Acquire Majority Stake 65 Arrives 65 Declares Quarterly Dividends 65 Complies With 65 Faces Lawsuit 65 Finalize Joint Venture 65 Delegation Visits 65 Patent Covering 65 Trading Halt 65 Resolves Dispute 64 Sweetens Bid 64 Amend Merger Agreement 64 Extends Term 64 Loses Appeal 64 Obtains Exclusive License 64 Winning Streak Continues 64 Accredits 64 Q4 Profit Declines 64 Goes Into 64 Develops Innovative 64 Becomes Largest 64 ADDING MULTIMEDIA 64 Inks Deals 64 Achieves Record 64 Dismisses 64 Inches Closer 64 Softens 64 Sets Sail 64 Unveil 64 Buy Majority Stake 64 Final Stages 64 Seizes 64 Expels 64 Files Lawsuit 64 Issues Clarification 64 Official Urges 64 Picks Up 64 Mulls Sale 64 Alert Issued 64 Being Investigated 64 Announces Conditional Approval 64 Reclassifies 64 Outbids 64 Gets Tentative 64 Unveils Expanded 64 Provides Comprehensive 64 Conditional Approval 64 Wholly Owned 64 Multimillion Dollar 64 Obtains Exclusive 64 Faces Obstacles 64 Develop Next Generation 64 Declares Increase 64 FDA Panel Recommends 64 Refines 64 File Lawsuit Against 64 Submits Supplemental 64 Causes Concern 64 Reports Third Quarter 64 Refocuses 64 Re Affirms 64 Grants Options 64 Energizes